Skip to main content
. 2021 Jan 6;16(1):e0244275. doi: 10.1371/journal.pone.0244275

Table 6. Association between perfusion values and overall survival times in GBM patients*.

Perfusion Values Hazard Ratio Wald Lower Wald Upper P value
rCBVmean of nonenhanced tumor (ratio) 2.373 0.603 9.343 0.22
rCBVmean of enhanced tumor (ratio) 0.943 0.736 1.209 0.65
rCBVmean of whole tumor (ratio) 1.004 0.801 1.257 0.98
rCBV5%max (ratio) 1.082 0.950 1.233 0.23
rCBV10%max (ratio) 1.077 0.927 1.253 0.33
rCBVhigh_perfusion (ratio) 1.010 0.910 1.120 0.85
rCBVvariation_mean of nonenhanced tumor 0.997 0.991 1.003 0.37
rCBVvariation_mean of enhanced tumor 0.996 0.986 1.006 0.40
rCBVvariation_mean of whole tumor 0.992 0.984 1.001 0.07
rCBVvariation_max of nonenhanced tumor 1.000 0.998 1.002 0.82
rCBVvariation_max of enhanced tumor 1.000 0.998 1.001 0.75
rCBVvariation_max of whole tumor 1.001 0.999 1.002 0.57

Note: * Association are calculated via Cox proportional hazard regression with adjustment of patient age at diagnosis, sex, histopathologic grade, extent of surgery, tumor volume, and therapeutic measures. rCBVmean, mean rCBV; rCBV5%max, 5% maximum rCBV; rCBV10%max, 10% maximum rCBV; rCBVhigh_perfusion, maximum rCBV; rCBVvariation_mean, mean rCBV variation; rCBVvariation_max, maximum rCBV variation.